Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Report Scope:

Chronic disease management includes various drug and medical device-based techniques used for the management of various chronic diseases. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for chronic disease management through various therapeutics and advanced device technologies. The format of this study includes the following -
- Detailed description, including demographics and cost burden, of various chronic diseases including cancer, diabetes, cardiovascular disorders, respiratory diseases, musculoskeletal disorders, neurological disorders, GI diseases, immune disorders, mental disorders and others (ostomy, urology disorders, chronic wounds etc.).
- Detailed description and analysis of current therapeutics (drugs, biologics) and device technologies (traditional medical devices, drug-device combinations, wearable and other monitoring devices).
- Market characterization, unmet need, market size and segmentation (by region, by segment, by diseases, by drug delivery, by treatment adherence, by health settings).
- Market drivers and restraints.
- Detailed market projections through 2024.
- Competition and market shares.
- Key marketed and pipeline (research and development) products along with information about their regulatory status.
- Strategic landscape (mergers and acquisitions).
- Regulatory structure.
- Pricing and reimbursement.
- Observations and conclusions on the future of chronic disease management.
- Profiles of market participants and associations.

Report Includes:

- 30 data tables and 46 additional tables
- Brief outline of the global markets and therapeutic device technologies for chronic disease management
- Analyses of global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Key insight into the current state of chronic diseases and disorders, with an emphasis on advance needle-free drug delivery technologies, diagnostic methods, and smart device technologies that support effective disease state management
- Data corresponding to global chronic disease management markets by disease type that includes various chronic diseases, therapeutic drugs, treatment adherence devices & systems, drug delivery technologies, and treatment & management providers
- Regulatory structure for pharmaceuticals and medical devices, pricing and reimbursement structure, marketed and pipeline products, and major developments influencing the market
- Detailed company profiles and competitive landscape of major market players, including Roche, AbbVie, Johnson & Johnson, Bristol-Myers Squibb, Merck and GlaxoSmithKline

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology and Information Sources
Geographic Breakdown
Analysts Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Chronic Diseases and Growing Burden on Economy
Background of Chronic Diseases
Epidemiology and Global Burden
Chronic Diseases Types
Cardiovascular Disease
Lifestyle Disorders
Cancer
Respiratory Disorders
Musculoskeletal Disorders
Mental/Mood Disorders
Gastro-Intestinal Disorders
Immune Disorders
Neurological Disorders
Other Chronic Disorders
Tobacco Smoking and Chronic Diseases
Aging, Gender and Chronic Diseases
Global Demographics
U.S. Demographics
U.S: Gender, Age and Life Expectancy
European Demographics
Japanese Demographics
Current Challenges and Future Directions
Chapter 4 Chronic Diseases: Therapeutics
Therapeutics and Chronic Diseases
Generic Drugs and Chronic Diseases
Generic Drugs vs. Branded Drugs
Continued Resistance for Generics
Biologics and Biosimilars for Immune-Mediated Chronic Diseases
Cancer and Targeted Therapy
Clinical Need of Therapeutics
Therapeutics and Cost Burden
Chronic Diseases and Managed Care
Key Marketed and Pipeline Products
Key Marketed Products
Key Pipeline/R&D Products
Unmet Need
Current Challenges and Future Developments
Chapter 5 Device Technologies and Applications
Medical Devices and Chronic Disease Management
Clinical and Market Need of Digital Therapeutics
Types of Device Technologies
Diagnostic and Monitoring Devices
Therapeutic Devices and Technologies
Key Marketed and R&D/Pipeline Products
Diagnostic and Monitoring Devices
Therapeutic Devices and Technologies
Advantages of Chronic Disease Management via Digital Care
Unmet Need
Future Developments for Healthcare and Safety Monitoring
Current Challenges
Future Outlook
Chapter 6 Chronic Diseases: Treatment Adherence Devices and Applications
Treatment Nonadherence
Market Need for Medication Adherence Systems and Applications
Types of Medication Adherence Systems and Applications
Hardware-Centric Medication Adherence Systems
Medication Adherence Software Applications
Key Marketed and Pipeline Products
Hardware-Centric Medication Adherence Systems
Medication Adherence Software Applications
Software and Mobile Application Advantages
Interconnectivity of Adherence App
Effectiveness of Smartphone Adherence Apps
Current Challenges
Future Developments
Chapter 7 Market Size and Growth Analysis
Market Size and Growth Analysis
Market Size and Growth Analysis, by Region
Market Size and Growth Analysis, by Product Segment
Market Size and Growth Analysis, by Chronic Disease Type
Market Size and Growth Analysis, by Treatment Provider and Target Health Settings
Market Growth Drivers and Restraints
Market Growth Drivers
Market Restraints
Chapter 8 Competitive Landscape in the Chronic Disease Management Market
Competitive Landscape: Chronic Disease Management with New Therapeutics and Advanced Device Technologies
Chapter 9 Strategies in the Chronic Disease Management Market
Consolidation in the Chronic Disease Management Market
Mergers and Acquisitions in the Chronic Disease Management Market
Recent Mergers and Acquisitions
Device Technologies
Therapeutics (Drugs and Biologics)
Minority Stakes and Future Options to Acquire
Future Strategic Landscape
Chapter 10 Regulatory Structure: Pharmaceuticals and Medical Devices
Regulatory Background
Regulatory Systems for Medical Devices, by Region
U.S.
European Union
Japan
Regulatory Systems for Pharmaceuticals, by Region
U.S.
Europe
Japan
Chapter 11 Pricing and Reimbursement: Pharmaceuticals and Medical Devices
Pricing and Reimbursement Background
Pricing and Reimbursement for Medical Devices, by Region
U.S.
Europe
Japan
Other Asia-Pacific
Pricing and Reimbursement for Pharmaceuticals, by Region
U.S.
Europe
Japan
Chapter 12 Conclusions - Outlook for Chronic Disease Management
Major Developments Influencing the Market
Technological Developments
Demographic and Economic Trends
Changing Structure of the Healthcare Industry
Lifestyle Medicine
Patient-Centric Programs
Long-Term Outlook for Chronic Disease Management
Chapter 13 Company Profiles
3RINGS
ABBOTT LABORATORIES
ABBVIE INC.
ACADIA PHARMACEUTICAL
ACORDA THERAPEUTICS
ACTUALMEDS
AGENUS
ACTAVIS PLC
ADHERIUM
AKRON
ALIVECOR
AMGEN INC.
AMIKO
ANIMAS (A SUBSIDIARY OF JOHNSON & JOHNSON)
ANI PHARMACEUTICALS
ALIPHCOM
ALLERGAN
ALKERMES
AMNEAL PHARMACEUTICALS
ANAVEX LIFE SCIENCES
APOTEX
ARCHOS
ARENA PHARMACEUTICALS
ARRAY BIOPHARMA
ASLAN PHARMACEUTICALS
ASAHI KASAI CORP.
ASPEN PHARMACARE
ASTRAZANECA PLC
ASTELLAS PHARMA INC.
ATHERSYS
AUDENTES THERAPEUTICS
AXIOBIONICS
AXSOME THERAPEUTICS
AYOGO HEALTH
BAUSCH HEALTH
BAYER AG
BESPAK EUROPE
BEIGENE
BIOXCEL THERAPEUTICS
BIOSENSICS
BIOSERENITY
BIOTRONIK GMBH
BIOTRICITY
BIOVOTION
BODYTEL
BOEHRINGER INGELHEIM
BOSTON SCIENTIFIC
BRISTOL-MYERS SQUIBB
BRAINMARC
BTS BIOENGINEERING
CARDIOMEMS INC. (A SUBSIDIARY OF ST. JUDE)
CELGENE
CHUGAI PHARMACEUTICALS CO., LTD.
CIPLA
CLEVELAND MEDICAL DEVICE
CLOVIS ONCOLOGY
CONNECTEDHEALTH PTE. LTD.
CORBUS PHARMACEUTICALS
CSPC PHARMACEUTICAL GROUP
DAIICHI SANKYO
DEXCOM INC.
DEPOMED INC.
DR. REDDYS LABORATORIES LTD.
EARLYSENSE
EDWARDS LIFESCIENCES CORP.
EISAI
ELI LILLY
EMPATICA
ENDO INTERNATIONAL
ENDOTRONIX
ENTRA HEALTH SYSTEMS
ENDOCEUTICS INC.
ERYTECH PHARMA
ESTEVE
EVERIST HEALTH
FIVE PRIME THERAPEUTICS
GLAXOSMITHKLINE PLC
GLOOKO, INC.
GILEAD SCIENCES
GLUCOVISTA INC.
GOODLUX TECHNOLOGY LLC
HALOZYME THERAPEUTICS
HEALTH CARE ORIGINALS
HIKMA PHARMACEUTICALS
HOCOMA
IHEALTH
IMMUNOMEDICS
IMPACT SPORTS TECHNOLOGIES
IMPAK HEALTH
INFOBIONIC INC.
INSULET CORP.
INTELESENS
INTRA-CELLULAR THERAPIES
IOVANCE BIOTHERAPEUTICS
IPSEN S.A.
JAN MEDICAL INC.
JIANGSU HENGRUI MEDICINE
JOHNSON & JOHNSON
LUNDBECK
LUPIN
KYOWA HAKKO KIRIN
LES LABORATOIRES SERVIER
LIVANOVA PLC
MALLINCKRODT PLC
MEDTRONIC
MEDTRONIC MINIMED INC. (A SUBSIDIARY OF MEDTRONIC)
MEDCONNECTIONS INC.
MEDMINDER
MENARINI
MERCK
MIO GLOBAL
MITSUBISHI TANABE PHARMA
MYLAN INC.
MYCARDIO LLC
NEMAURA MEDICAL INC.
NEOFECT CO., LTD.
NEUROCRINE BIOSCIENCES
NEUROMETRIX INC.
NEUROVIGIL INC.
NOVARTIS
NOVO NORDISK
NOVASOM INC.
NUCANA
OMADA HEALTH INC.
OMRON CORP.
OMNICELL INC.
ONO PHARMACEUTICAL CO., LTD.
ORION PHARMA LTD.
ORPYX MEDICAL TECHNOLOGIES
OTSUKA PHARMACEUTICALS
PACIRA PHARMACEUTICALS INC.
PFIZER
PHILOSYS
POLAR ELECTRO OY
PREVENTICE INC.
PRESCRIBEWELLNESS LLC
PRIZM MEDICAL INC.
PROPELLER HEALTH
PROTEUS DIGITAL HEALTH INC.
PROTEOSTASIS THERAPEUTICS
QARDIO
REHAB-ROBOTICS (A MEMBER OF VINCENT MEDICAL HOLDINGS)
REXAHN PHARMACEUTICALS
ROCHE
SAGE THERAPEUTICS
SANOFI
SAREPTA THERAPEUTICS
SENSE4CARE
SENSEONICS HOLDINGS
SENTICARE INC.
SHANGHAI PHARMACEUTICALS HOLDING
SHIONOGI AND CO., LTD.
SILVERGENS
SPROUTLING INC. (ACQUIRED BY MANTTEL)
ST. JUDE MEDICAL (A SUBSIDIARY OF ABBOTT LABORATORIES)
STADA ARZNEIMITTEL AG
SUMITOMO DAINIPPON PHARMA CO., LTD.
SUN PHARMACEUTICAL INDUSTRIES
TAKEDA PHARMACEUTICAL CO., LTD.
TAISHO PHARMACEUTICAL
TCR2 THERAPEUTICS
TEVA PHARMACEUTICAL INDUSTRIES
TOWERVIEW HEALTH, INC.
TRANSLATE BIO
TYME TECHNOLOGIES
UCB
UNILIFE CORP.
VERTEX PHARMACEUTICAL
VAICA
VITAL CONNECT
WEST PHARMACEUTICAL SERVICES INC.
WINMEDICAL SRL
YBRAIN
YPSOMED HOLDING AG
ZOGENIX INC.
ZYDUS CADILA
Chapter 14 Appendix A: List of Acronyms
Chapter 15 Appendix B: Professional Organizations
American Heart Association
Center for Drug Evaluation and Research (CDER)
Center for Devices and Radiological Health (CDRH)
Centers for Medicare and Medicaid Services (CMS)
European Databank for Medical Devices (EUDAMED)
Food and Drug Administration (FDA or USFDA)
Hormone Foundation
International Diabetes Federation (IDF)
International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
Network for Excellence in Health Innovation (NEHI)
National Center for Biotechnology Information (NCBI)
National Institute of Aging (NIA)
Pharmaceuticals and Medical Devices Agency (PMDA)
World Cancer Research Fund International
World Health Organization (WHO)

List Of Tables


Summary Table : Overall Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Region, Through 2024
Table 1 : Global Deaths Share, by Various Chronic Disease Types, 2018
Table 2 : Global DALYs Share, by Various Chronic Disease Types, 2018
Table 3 : Global Incidence Share of Hypertension, by Patient Group Type, 2018
Table 4 : Global Prevalence of Angina Pectoris and Stroke (Survivors), Through 2030
Table 5 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
Table 6 : Structural Heart Disease, Management Through Medication
Table 7 : BMI Calculation
Table 8 : BMI Categories Based on Increasing Health Risks
Table 9 : Trends in Obesity Composition of the Worlds Population, Through 2025
Table 10 : U.S. Obesity and Severe Obesity vs. General Population, Through 2025
Table 11 : Global Diabetes Types Share
Table 12 : Global Prevalence of Diabetes, by Type, Through 2040
Table 13 : Global Prevalence of Breast Cancer, by Country/Region, Through 2025
Table 14 : Global Epidemiology of Colorectal Cancer, by Region, Through 2030
Table 15 : Global Deaths, by Various Cancer Types, Through 2030
Table 16 : Global Deaths Share, by Various Cancer Types, 2015
Table 17 : Global Symptomatic Prevalence of Key Musculoskeletal Disorders, Through 2025
Table 18 : Global Deaths, by Various Musculoskeletal Disorders, Through 2030
Table 19 : Global Deaths from Digestive Diseases, by Region, Through 2025
Table 20 : Estimated World Population and Annual Growth, by Selected Age Group, Through 2030
Table 21 : World Population, by Selected Region, Through 2030
Table 22 : U.S. Population Estimates and Projections, by Age Group, Through 2030
Table 23 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, Through 2020
Table 24 : European Population Estimates and Projections, by Age Group, Through 2030
Table 25 : Japanese Population Estimates and Projections, by Age Group, Through 2030
Table 26 : Key Marketed Products, Respiratory Disorders - Therapeutics
Table 27 : Key Marketed Products, Mood Disorders - Therapeutics
Table 28 : Key Marketed Products, Musculoskeletal Disorders - Therapeutics
Table 29 : Key Marketed Products, Neurovascular Disorders - Therapeutics
Table 30 : Key Marketed Products, Immune Disorders - Therapeutics
Table 31 : Key Marketed Products, Diabetes - Therapeutics
Table 32 : Key Marketed Products, Cardiovascular Disorders - Therapeutics
Table 33 : Key Marketed Products, GI Disorders - Therapeutics
Table 34 : Key Marketed Products, Cancer - Therapeutics
Table 35 : Key Pipeline/R&D Products, Cancer - Therapeutics
Table 36 : Key Pipeline/R&D Products, Neurological Disorders - Therapeutics
Table 37 : Key Pipeline/R&D Products, Cardiovascular Disorders - Therapeutics
Table 38 : Key Pipeline/R&D Products, GI Disorders - Therapeutics
Table 39 : Key Pipeline/R&D Products, Musculoskeletal Disorders - Therapeutics
Table 40 : Key Pipeline/R&D Products, Diabetes - Therapeutics
Table 41 : Key Pipeline/R&D Products, Mood Disorders - Therapeutics
Table 42 : Key Marketed and Pipeline/R&D Devices, Cardiac Monitoring Devices and Technologies
Table 43 : Key Marketed and Pipeline/R&D Devices, Continuous Glucose monitoring Devices and Technologies
Table 44 : Key Marketed and Pipeline/R&D Devices, Sleep-Monitoring Devices
Table 45 : Key Marketed and Pipeline/R&D Devices, Vital Sign and Activity Monitoring Devices and Technologies
Table 46 : Key Marketed and Pipeline/R&D Devices, Pain Management Devices and Technologies
Table 47 : Key Marketed and Pipeline/R&D Devices, Drug delivery Devices and Technologies
Table 48 : Smart Pills for Patient Monitoring
Table 49 : Smart Pills for Oral Drug Delivery
Table 50 : Key Marketed and Pipeline/R&D Devices, Insulin delivery Devices and Technologies
Table 51 : Global Medication Adherence Percentages, by Chronic Diseases
Table 52 : Automated Medication Dispensing Cabinets
Table 53 : Smart Pill Dispensers, Pillboxes and Organizers
Table 54 : Medication Tracking Devices and Apps
Table 55 : Pill Organizer and Reminder Systems
Table 56 : Smart Pill Cap and Bottle Systems
Table 57 : Other Medication Adherence Solutions
Table 58 : Health and Medication Reminder Apps
Table 59 : Personalized Medication Adherence and Text Messaging Apps
Table 60 : Health and Medication Monitoring Apps
Table 61 : Cloud-Based Adherence Solutions and Databases
Table 62 : Health and Medication Adherence Apps
Table 63 : Other Medication adherence Apps
Table 64 : Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Region, Through 2024
Table 65 : Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Product Segment, Through 2024
Table 66 : Global Market for Treatment Adherence Systems and Applications for Chronic Disease Management, by Segment, Through 2024
Table 67 : Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Disease Type, Through 2024
Table 68 : Global Market for Chronic Disease Management Therapeutics, by Leading Company, 2018
Table 69 : Global Market for Chronic Disease Management Device Technologies, by Leading Company, 2018
Table 70 : Key Strategic Deals in the Chronic Disease Management and Device Technology Market, 2012-2019
Table 71 : Key Strategic Deals in Chronic Disease Management Therapeutics Market, 2016-2019
Table 72 : Key Strategic Deals for Business Units, Minority Stakes and Future Options to Acquire in the Chronic Disease Management Market, 2016-2019
Table 73 : Differences in Regulatory Approval in the U.S. and Europe
Table 74 : Trends in Per Capita Real Gross Domestic Product Growth, by Region, 2015-2018
Table 75 : List of Acronyms Used in Chronic Disease Management

List Of Figures


Summary Figure : Overall Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Region, 2018-2024
Figure 1 : Global Deaths Share, by Various Chronic Disease Types, 2018
Figure 2 : Global DALYs Share, by Various Chronic Disease Types, 2018
Figure 3 : Global Incidence Share of Hypertension, by Patient Group Type, 2018
Figure 4 : Global Prevalence of Angina Pectoris and Stroke (Survivors), 2004-2030
Figure 5 : Global Prevalence of Congestive Heart Failure and Stroke, 2004-2030
Figure 6 : Trends in Obesity Composition of the Worlds Population, 2012-2025
Figure 7 : U.S. Obesity and Severe Obesity vs. General Population, 2018-2025
Figure 8 : Global Diabetes Types Share
Figure 9 : Global Prevalence of Diabetes, by Type, 2018-2040
Figure 10 : Global Prevalence of Breast Cancer, by Country/Region, 2018-2025
Figure 11 : Global Epidemiology of Colorectal Cancer, by Region, 2000-2030
Figure 12 : Global Deaths, by Various Cancer Types, 2000-2030
Figure 13 : Global Deaths Share, by Various Cancer Types, 2015
Figure 14 : Global Symptomatic Prevalence of Key Musculoskeletal Disorders, by Region, 2018
Figure 15 : Global Deaths Share, by Various Musculoskeletal Disorders, 2015
Figure 16 : Global Deaths from Digestive Diseases, by Region, 2018-2025
Figure 17 : Estimated World Population and Annual Growth, by Selected Age Group, 2000-2030
Figure 18 : World Population, by Selected Region, 2000-2030
Figure 19 : U.S. Population Estimates and Projections, by Age Group, 2000-2030
Figure 20 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, 2005-2020
Figure 21 : European Population Estimates and Projections, by Age Group, 2000-2030
Figure 22 : Japanese Population Estimates and Projections, by Age Group, 2000-2030
Figure 23 : Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Region, 2018-2024
Figure 24 : Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Product Segment, 2018-2024
Figure 25 : Global Market Share for Therapeutics, by Drug Type, 2018
Figure 26 : Global Market Share for Therapeutics, by Delivery Technology, 2017
Figure 27 : Global Market Share for Device Technologies, by Device Type, 2017
Figure 28 : Global Market for Treatment Adherence Systems and Applications for Chronic Disease Management, by Segment, 2018-2024
Figure 29 : Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Disease Type, 2018-2024
Figure 30 : Global Market Share for Therapeutics and Device Technologies, by Treatment Provider and Target Health Settings, 2017
Figure 31 : Global Market Share for Chronic Disease Management Therapeutics, by Leading Company, 2018
Figure 32 : Global Market Share for Chronic Disease Management Device Technologies, by Leading Company, 2018
Figure 33 : Trends in Per Capita Real Gross Domestic Product Growth, by Region, 2015-2018

Global Biosimilars Market- By Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), By Manufacturing (In-house, Contract), By Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease)and By Region (North America, Europe, Asia Pacific, South America, Middle East, & Africa)- Global forecast from 2020-2027.

Global Biosimilars Market- By Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), By Manufacturing (In-house, Contract), By Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease)and By Region (North America, Europe, Asia Pacific, South America, Middle East, & Africa)- Global forecast from 2020-2027. market research report available in single user pdf license with Aarkstore Enterprise at USD 4950

USD 4950 View Report

Global Chronic Disease Management Market Research Report 2020-2024

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Atomic Force Microscope Report by Material, Application, and

USD 2850 View Report

Global Biosimilars Market- By Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), By Manufacturing (In-house, Contract), By Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease)and By Region (North America, Europe, Asia Pacific, South America, Middle East, & Africa)- Global forecast from 2020-2027.

Global Biosimilars Market- By Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), By Manufacturing (In-house, Contract), By Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease)and By Region (North America, Europe, Asia Pacific, South America, Middle East, & Africa)- Global forecast from 2020-2027. market research report available in single user pdf license with Aarkstore Enterprise at USD 4950

USD 4950 View Report

Global Chronic Disease Management Market Research Report 2020-2024

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Atomic Force Microscope Report by Material, Application, and

USD 2850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available